Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
The Efficacy of Certolizumab Pegol over 4 Years in Psoriatic Arthritis Patients With and Without Concomitant Use of DMARDs. Scottish Society of Rheumatology Autumn Meeting, SSR 2017, Dunfermline, UK, Oct 2017
Scottish Society of Rheumatology Autumn Meeting, SSR 2017 (2017)
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Link
Disciplines
Publication Date
October, 2017
Citation Information
Philip Mease and et.al.. "The Efficacy of Certolizumab Pegol over 4 Years in Psoriatic Arthritis Patients With and Without Concomitant Use of DMARDs. Scottish Society of Rheumatology Autumn Meeting, SSR 2017, Dunfermline, UK, Oct 2017" Scottish Society of Rheumatology Autumn Meeting, SSR 2017 (2017)
Available at: http://works.bepress.com/philip-mease/189/